Medical Bulletin 15/ January/ 2025 Dr. Bhumika Maikhuri15 Jan 2025 3:00 PM ISTHere are the top medical news for the day:Computer Model as Guide for Treatment Selection in Chronic Myelogenous Leukemia: Study FindsResearchers, in...
Computer Model as Guide for Treatment Selection in Chronic Myelogenous Leukemia: Study Reveals Dr. Bhumika Maikhuri15 Jan 2025 8:00 AM ISTResearchers, in a new study, used their computer model as a guide for treatment selection for patients with chronic myelogenous leukaemia. The study...
Sun Pharma Advanced Research Company halts Parkinson's disease drug trial Ruchika Sharma10 April 2024 2:42 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced results of interim analysis from the PROSEEK study, a global,...
SPARC concludes enrolment in global Phase 2 study of Vodobatinib in early Parkinson's disease Ruchika Sharma30 Oct 2023 11:30 AM ISTVodobatinib is a potential first-in-class, highly selective and brain penetrating c-Abl inhibitor.
Medical Bulletin 29/September/2023 Isra Zaman29 Sept 2023 3:15 PM ISTHere are the top medical news of the day:FDA approves Bosutinib for pediatric Chronic Myelogenous Leukemia patientsOn September 26, 2023, the Food and...
FDA approves Bosutinib for pediatric Chronic Myelogenous Leukemia patients Isra Zaman29 Sept 2023 10:15 AM ISTOn September 26, 2023, the Food and Drug Administration (FDA) granted approval for the use of bosutinib in pediatric patients aged 1 year and older...
NeoDx Biotech Labs Pvt Ltd announces BCR ABL Product Launch MD Brand Connect1 Feb 2023 4:25 PM ISTNeoDx's BCR-ABL Qualitative and Quantitative is a one-step, multiplex format along with ABL amplification in a single tube.
